Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Am J Clin Pathol ; 139(5): 587-98, 2013 May.
Article in English | MEDLINE | ID: mdl-23596110

ABSTRACT

An immunohistochemical study was conducted of 108 papillary carcinoma cases, including 48 cases with intratumoral heterotopic ossification (IHO). In 48 cases, papillary carcinoma with IHO was accompanied by nodular fibrosis. Cases of papillary carcinoma with IHO or nodular fibrosis showed higher incidences of lymph node metastasis, multifocal lesions, and extrathyroidal invasion than those without IHO and nodular fibrosis. A higher number of stromal myofibroblasts was observed in papillary carcinoma with IHO or nodular fibrosis than in that without fibrosis. Expression of both basic fibroblast growth factor (bFGF) and bone morphogenetic protein (BMP)-2 was the highest in papillary carcinoma with IHO. Papillary carcinoma with IHO showed higher vascular invasion and higher numbers of capillaries expressing nestin, which is associated with high expression of vascular endothelial growth factor (VEGF). Papillary carcinoma with IHO is a unique subtype with extensive progression including frequent lymph node metastasis, multifocality, and invasive behavior. Papillary carcinoma with IHO was correlated with expression of bFGF, BMP-2, and VEGF in the carcinoma cells, leading to neovascularization.


Subject(s)
Adenocarcinoma, Papillary/secondary , Ossification, Heterotopic/pathology , Thyroid Neoplasms/pathology , Adenocarcinoma, Follicular/blood supply , Adenocarcinoma, Follicular/metabolism , Adenocarcinoma, Follicular/secondary , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/metabolism , Biomarkers, Tumor/metabolism , Bone Morphogenetic Protein 2 , Capillaries/metabolism , Capillaries/pathology , Disease Progression , Fibroblast Growth Factor 2/metabolism , Fibrosis/pathology , Humans , Intermediate Filament Proteins/metabolism , Lymph Nodes/pathology , Lymphatic Metastasis , Microcirculation , Middle Aged , Neoplasms, Multiple Primary , Neovascularization, Pathologic , Nerve Tissue Proteins/metabolism , Nestin , Ossification, Heterotopic/metabolism , Thyroid Neoplasms/blood supply , Thyroid Neoplasms/metabolism , Vascular Endothelial Growth Factor A/metabolism
2.
Arch Gynecol Obstet ; 284(5): 1169-73, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21184091

ABSTRACT

PURPOSE: Congenital anomalies of the inferior vena cava (IVC) are not commonly recognized since they generally do not cause symptoms. METHODS: Preoperative cross-sectional imaging can identify anomalies of vascular structures that are highly relevant to the pelvic surgeon. The clinical impact of congenital vascular variations of IVC, especially on paraaortic lymphadenectomy, is investigated. RESULTS: In case the surgeon is unaware of these anomalies, impending differential diagnostic confusion (paraaortic adenopathy), intraoperative blood loss and the need for transfusion may occur. The development of IVC is a complex process concerning the formation of several anastomoses between three paired embryonic veins (posterior cardinal, subcardinal, supracardinal veins). In double IVC, the left IVC typically ends at the level of the left renal vein, in an anastomosis which crosses anterior to the aorta to join the normal right IVC. CONCLUSION: Anomalies of IVC are present in 0.4-3.5% of women. As different aberrations of IVC have important clinical implications, awareness of retroperitoneal abnormal vessels is crucial to avoid diagnostic pitfalls and intraoperative complications.


Subject(s)
Adenocarcinoma, Papillary/blood supply , Ovarian Neoplasms/blood supply , Pelvis/blood supply , Vena Cava, Inferior/abnormalities , Adenocarcinoma, Papillary/diagnostic imaging , Adenocarcinoma, Papillary/drug therapy , Adenocarcinoma, Papillary/surgery , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carboplatin/therapeutic use , Deoxycytidine/analogs & derivatives , Deoxycytidine/therapeutic use , Female , Humans , Lymphatic Metastasis , Middle Aged , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/surgery , Pelvis/embryology , Pelvis/surgery , Radiography , Treatment Outcome , Vascular Malformations/embryology , Vascular Malformations/surgery , Vena Cava, Inferior/embryology , Vena Cava, Inferior/surgery , Gemcitabine
3.
Int J Surg Pathol ; 18(3): 193-200, 2010 Jun.
Article in English | MEDLINE | ID: mdl-18611928

ABSTRACT

To investigate the possible roles of E-selectin and its ligand, Sialyl Lewis X, in lymph node metastasis of invasive micropapillary carcinoma of the breast, 100 cases of invasive micropapillary carcinoma and 97 cases of invasive ductal carcinoma were analyzed immunohistochemically for the expression of E-selectin and Sialyl Lewis X, along with CD34, to measure the microvessel density of invasive micropapillary carcinoma. We found that the number of E-selectin-positive vessels was greater in invasive micropapillary carcinoma than in invasive ductal carcinoma, and it was significantly correlated with the histological grade, the number of positive lymph nodes, and the microvessel density of invasive micropapillary carcinoma. The Sialyl Lewis X expression of invasive micropapillary carcinoma was higher than that of invasive ductal carcinoma, which was also associated with lymph node metastasis. In invasive micropapillary carcinoma, the Sialyl Lewis X expression was predominantly in the stroma-facing surface of the cell clusters and the adjacent stroma, while in invasive ductal carcinoma it was largely intracytoplasmic or intercellular. These findings suggested that E-selectin and Sialyl Lewis X might play an important role in lymph node metastasis in invasive micropapillary carcinoma. The expression pattern of Sialyl Lewis X in invasive micropapillary carcinoma suggested that the reversal of cell polarity of invasive micropapillary carcinoma might be as an important factor for the morphogenesis and possibly the pathogenesis, especially their higher rates of lymph node metastasis.


Subject(s)
Adenocarcinoma, Papillary/secondary , Biomarkers, Tumor/metabolism , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/secondary , E-Selectin/metabolism , Lymph Nodes/metabolism , Oligosaccharides/metabolism , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/metabolism , Breast Neoplasms/metabolism , Carcinoma, Ductal, Breast/blood supply , Carcinoma, Ductal, Breast/metabolism , Cell Polarity , Female , Humans , Lymph Nodes/pathology , Lymphatic Metastasis , Microvessels/pathology , Neoplasm Invasiveness , Sialyl Lewis X Antigen
5.
Bull Cancer ; 96(1): 95-101, 2009 Jan.
Article in French | MEDLINE | ID: mdl-19211364

ABSTRACT

During last decade, many progresses have been made in the understanding of thyroid cancer molecular biology. This knowledge led to the development of novel targeted therapy in iodine-resistant patients. However, the management of patients remains complex because of the broad spectrum of clinical presentation of thyroid cancers, differences in their natural histories and the lack of data about randomized trials. Angiogenesis inhibitors (sorafenib, motesanib, axitinib and vandetanib) have shown promising activity in differentiated thyroid cancer. Vandetanib, an inhibitor of RET and VEGFR tyrosine-kinases, is promising in medullary thyroid cancers. Preliminary results of these trials are discussed in this review.


Subject(s)
Adenocarcinoma, Follicular/drug therapy , Adenocarcinoma, Papillary/drug therapy , Angiogenesis Inhibitors/therapeutic use , Protein Kinase Inhibitors/therapeutic use , Thyroid Neoplasms/drug therapy , Adenocarcinoma, Follicular/blood supply , Adenocarcinoma, Follicular/genetics , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/genetics , Drug Resistance, Neoplasm , Humans , Iodine Radioisotopes/therapeutic use , Thyroid Neoplasms/blood supply , Thyroid Neoplasms/genetics
6.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 31(3): 414-6, 419, 2006 Jun.
Article in Chinese | MEDLINE | ID: mdl-16859137

ABSTRACT

OBJECTIVE: To investigate the relationship between the expression of vascular endothelial growth factor C (VEGF-C) and angiogenesis and lymphangiogenesis in papillary thyroid carcinoma (PTC). METHODS: Seventy-two PTC cases were divided into 3 groups according to the level of invasion: papillary microcarcinoma group (PMC group), intrathyroid carcinoma group (IPC group), and extrathyroid carcinoma group (EPC group). They were again divided into 2 groups according to lymph node metastasis: lymph node metastasis group and lymph node no-metastasis group. The expressions of VEGF-C, CD105 and vascular endothelial growth factor receptor-3 (VEGFR-3) were detected by SP method of immunohistochemical staining. The expression of VEGF-C was analyzed quantitatively by image analysis system, and the PI of VEGF-C (VEGF-C-PI), the number of MVD (microvessel density), and LVD (lymphaticvessel density) were obtained. RESULTS: The VEGF-C-PI of lymph node metastasis group (23.15 +/- 3.75) was higher than that of lymph node non-metastasis group (14.54 +/- 2.93) (P <0.01). MVD was 35.25 +/- 2.06 in the PMC group, 41.75 +/- 5.46 in the IPC group, and 52.58 +/- 4.16 in the EPC group, which showed the elevatory tendency with the increase of invasion (P < 00.5). LVD was 6.00 +/- 0.81 in the PMC group, 13.80 +/- 1.81 in the IPC group, and 19.17 +/- 2.96 in the EPC group, which again showed the elevatory tendency with the increase of invasion (P <0.05). The LVD of lymph node metastasis group (19.56 +/- 2.45) was significantly higher than that of lymph node non-metastasis group (12.48 +/- 2.84) (P < 0.05). VEGF-C was positively correlated with MVD and LVD (r = 0.743, 0.90, P <0.01). CONCLUSION: The expressions of VEGF-C and LVD are related to lymph node metastasis of PTC. MVD and LVD are related to the invasion of PTC. VEGF-C may play an important role in the angiogenesis and lymphangiogenesis.


Subject(s)
Adenocarcinoma, Papillary/metabolism , Lymphangiogenesis , Neovascularization, Pathologic/metabolism , Thyroid Neoplasms/metabolism , Vascular Endothelial Growth Factor C/biosynthesis , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/pathology , Adolescent , Adult , Aged , Child , Female , Humans , Male , Middle Aged , Thyroid Neoplasms/blood supply , Thyroid Neoplasms/pathology , Vascular Endothelial Growth Factor C/genetics
7.
Zhonghua Zhong Liu Za Zhi ; 26(11): 673-7, 2004 Nov.
Article in Chinese | MEDLINE | ID: mdl-15777506

ABSTRACT

OBJECTIVE: To investigate whether correlation exists between mRNA expression of IGF-II and hepatocyte growth factor (HGF) and tumor progression and prognosis in gastric cancer. METHODS: In situ hybridization technique was used to examine mRNA expression of IGF-II and HGF, and immunohistochemical technique was used to examine protein expression of CD34 in 105 specimens of gastric carcinoma. RESULTS: In situ hybridization revealed that the positive rates of IGF-II mRNA and HGFmRNA were 49.5% and 57.1%, respectively. In stage T3-T4 cases, positive mRNA expression rates of IGF-II and HGF, the frequencies of vessel invasion, lymph node metastasis and distant metastasis were significantly higher than those in stage T1-T2 cases. The mean microvascular density (MVD) in stage T3-T4 tumors, vessel invasion, lymph node metastasis and distant metastasis were significantly more frequent than those in stage T1-T2 tumors. The mean MVD in tumors with positive IGF-II and HGF expressions was significantly higher than that in tumors without IGF-II and HGF expression. There were positive correlations between MVD and expression of IGF-II and HGF. The mean survival time and 5-year survival rate in cases with positive IGF-II and HGF expression and MVD value > or = 39.5 were significantly shorter those that in cases with negative IGF-II and HGF expression and MVD value < 39.5. CONCLUSION: IGF-II and HGF promote angiogenesis in gastric cancer, and take part in tumor invasion and metastasis. They can be used as prognostic markers of gastric cancer in clinical practice.


Subject(s)
Carcinoma, Ductal/metabolism , Hepatocyte Growth Factor/biosynthesis , Insulin-Like Growth Factor II/biosynthesis , Neovascularization, Pathologic , Stomach Neoplasms/metabolism , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/metabolism , Adenocarcinoma, Papillary/secondary , Adult , Aged , Carcinoma, Ductal/blood supply , Carcinoma, Ductal/secondary , Carcinoma, Signet Ring Cell/blood supply , Carcinoma, Signet Ring Cell/metabolism , Carcinoma, Signet Ring Cell/secondary , Disease Progression , Female , Hepatocyte Growth Factor/genetics , Humans , Insulin-Like Growth Factor II/genetics , Liver Neoplasms/blood supply , Liver Neoplasms/metabolism , Liver Neoplasms/secondary , Lymphatic Metastasis , Male , Microcirculation , Middle Aged , Neoplasm Invasiveness , Peritoneal Neoplasms/blood supply , Peritoneal Neoplasms/metabolism , Peritoneal Neoplasms/secondary , Prognosis , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Stomach Neoplasms/blood supply , Stomach Neoplasms/pathology , Survival Rate
8.
Neurol Res ; 25(3): 237-40, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12739230

ABSTRACT

Endolymphatic sac tumors are rare, low-grade adenocarcinomas of the petrous bone. These tumors are highly vascularized and surgical removal is often challenging. We present a staged endovascular-neurosurgical approach consisting of stent-assisted angioplasty of the petrous carotid, selective endovascular embolization and surgical removal.


Subject(s)
Adenocarcinoma, Papillary/surgery , Neurosurgical Procedures/methods , Petrous Bone/surgery , Skull Neoplasms/surgery , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/diagnostic imaging , Adenocarcinoma, Papillary/metabolism , Adenocarcinoma, Papillary/pathology , Adult , Angioplasty , Carotid Artery, Internal/surgery , Embolization, Therapeutic , Humans , Immunohistochemistry , Male , Petrous Bone/blood supply , Petrous Bone/diagnostic imaging , Petrous Bone/metabolism , Petrous Bone/pathology , Skull Neoplasms/blood supply , Skull Neoplasms/diagnostic imaging , Skull Neoplasms/metabolism , Skull Neoplasms/pathology , Stents , Tomography, X-Ray Computed
9.
J Neurosurg Sci ; 45(3): 177-80, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11731743

ABSTRACT

We present the case of a patient with an endolymphatic sac tumour (ELST). This rare tumour entity has only recently been defined and despite a well characterized clinical appearance misdiagnosis as jugular paraganglioma is frequent. A 68-year-old woman was admitted to our Neurosurgical Department with a mass lesion extending from the left temporal bone to the cerebello-pontine angle (CPA). Radiological features were high vascularization, contrast enhancement and destruction of the os petrosum. After preoperative angiographic embolization the tumour was removed in two surgical interventions, first via a lateral suboccipital approach and second by petrosectomy. The lesion proved to be a typical endolymphatic sac tumour by a synopsis of histological, radiological and clinical features. ELST should be taken into consideration in patients with mass lesions in the cerebellopontine angle destroying the petrous bone and resembling paraganglioma. Since slow growth rate and lack of metastases are particular features of ELST, complete resection of the tumour results in long survival times without adjuvant chemo- or radiotherapy.


Subject(s)
Adenocarcinoma, Papillary/pathology , Adenocarcinoma, Papillary/surgery , Petrous Bone , Skull Neoplasms/pathology , Skull Neoplasms/surgery , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/diagnostic imaging , Aged , Embolization, Therapeutic , Female , Humans , Neurosurgical Procedures , Preoperative Care , Skull Neoplasms/blood supply , Skull Neoplasms/diagnostic imaging , Tomography, X-Ray Computed
10.
Zhonghua Zhong Liu Za Zhi ; 20(5): 351-3, 1998 Sep.
Article in Chinese | MEDLINE | ID: mdl-10921029

ABSTRACT

OBJECTIVES: To study the effect of ectopic HCG on microvessel density in gastric carcinoma using immunohistochemical staining with anti-beta-HCG polyclonal antibody and anti-factor VIII related antigen(FVIII RAg)antibody. METHODS: A total of 40 specimens resected from patients with gastric carcinoma was investigated by immunohistochemical staining with a anti-beta-HCG polyclonal antibody and a monoclonal antibody against FVIII RAg. The expression of beta-HCG and the microvessel density(the average number of microvessel in three areas of highest vascular density at 400 x magnification) in various regions of the histologic specimens were studied. RESULTS: Fifteen (37.5%) of the 40 gastric carcinomas was positive for beta-HCG protein in tumor tissue. beta-HCG protein was negative in the tumor-adjacent and in normal tissue. The mean microvessel density was 27.4 +/- 7.1 in the tumor, 11.9 +/- 5.4 in tumor-adjacent and 4.8 +/- 1.5 in normal tissues (P < 0.05-0.01). There was a close correlation with beta-HCG positivity and microvessel density (MVD). There was no correlation between the degree of tumor cell differentiation and beta-HCG expression, nor was a correlation between it and MVD. High expression level of beta-HCG and MVD was significantly associated with hematogenous metastases. CONCLUSION: Ectopic HCG expression may have angiogenic effect which, in turn, may facilitate hematogenous dissemination of gastric cancer.


Subject(s)
Chorionic Gonadotropin, beta Subunit, Human/biosynthesis , Stomach Neoplasms/metabolism , Adenocarcinoma/blood supply , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/metabolism , Adenocarcinoma, Papillary/pathology , Adult , Aged , Carcinoma, Signet Ring Cell/blood supply , Carcinoma, Signet Ring Cell/metabolism , Carcinoma, Signet Ring Cell/pathology , Female , Humans , Liver Neoplasms/blood supply , Liver Neoplasms/metabolism , Liver Neoplasms/secondary , Male , Microcirculation/pathology , Middle Aged , Stomach Neoplasms/blood supply , Stomach Neoplasms/pathology
11.
Hinyokika Kiyo ; 43(4): 291-4, 1997 Apr.
Article in Japanese | MEDLINE | ID: mdl-9161859

ABSTRACT

We report a case of Bellini duct carcinoma of the left kidney with invasive growth pattern. A 39-year-old man was admitted to our hospital with the chief complaint of gross hematuria. Ultrasonography showed left renal swelling but normal reniform configuration of the kidney was maintained. Computed tomography demonstrated a low density tumor infiltrating into the renal cortex and with tumor extension into the renal vein. Renal angiography revealed a hypovascular tumor. We suspected a left renal cell carcinoma with tumor extension into the left renal vein, and performed radical nephrectomy. Macroscopically, the resected kidney had a normal outer contour. The tumor with infiltrative growth pattern existed in renal medulla. Histopathologic examination revealed a papillary adenocarcinoma originated in Bellini duct (pT3bN2M0). The patient underwent systemic chemotherapy (M-VAC). This case showed invasive growth pattern, which were different from the usual renal cell carcinoma and Bellini duct carcinoma.


Subject(s)
Adenocarcinoma, Papillary/pathology , Kidney Neoplasms/pathology , Kidney Tubules, Collecting/pathology , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/drug therapy , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cisplatin/administration & dosage , Doxorubicin/administration & dosage , Humans , Kidney Neoplasms/blood supply , Kidney Neoplasms/drug therapy , Male , Methotrexate/administration & dosage , Neoplasm Invasiveness , Vinblastine/administration & dosage
13.
Nihon Jibiinkoka Gakkai Kaiho ; 98(8): 1270-7, 1995 Aug.
Article in Japanese | MEDLINE | ID: mdl-7472764

ABSTRACT

In this study, the usefulness of three-dimensional angiographic imagings from helical scanning computed tomography (CT) enhanced by contrast media were evaluated based on results from three patients with a cervical mass, e.g. thyroid cancer and carotid body tumor. Three-dimensional CT (3D-CT) angiographic imagings in these cases clearly demonstrated secondary dislocation or distortion of the major cervical vessels caused by the tumor or metastatic lymph nodes. It was remarkable that in the highly vascularized tumor in case 3, all features of the tumor were delineated by 3D-CT angiography. Our results indicate that 3D-CT angiographic imagings are especially useful for preoperative evaluation of the relationship of the cervical mass to major cervical vessels as well as in the observation of tumors rich in vasculature.


Subject(s)
Adenocarcinoma, Papillary/blood supply , Carotid Arteries/diagnostic imaging , Carotid Body Tumor/blood supply , Thyroid Neoplasms/blood supply , Tomography, X-Ray Computed/methods , Adult , Aged , Female , Humans , Male , Middle Aged
14.
Hokkaido Igaku Zasshi ; 68(2): 251-64, 1993 Mar.
Article in Japanese | MEDLINE | ID: mdl-8509067

ABSTRACT

In the clinical research on angiographic diagnosis of thyroid tumor over twenty years, techniques, diagnostic points and limitations in angiogram were studied, and its indications and significance were reviewed. 1) As about 80% of the feeding artery for thyroid tumor was the superior thyroid artery, superior and inferior thyroid angiography via the femoral artery can be a basic method for angiographic diagnosis. 2) The success rate of insertion into superior and inferior thyroid artery depended on age, vascular anatomy, the shape of catheter, technique and procedure. The success rate was improved from 57.3% to 86.9% by reconsideration and devices. 3) The diagnostic points in thyroid angiographic findings are the morphological character of tumor vessel, the margin of tumor stain and the condition of its density. By checking these three points, the correct diagnostic rate of 94.7% was obtained in the differential diagnosis of malignant and benign. 4) Microangiogram and pathological findings of resected specimen were compared. The results suggest that the variety of width and distribution of vascular space in tumor and secondary degeneration prevent accurate diagnosis. 5) Today, noninvasive diagnostic methods for thyroid tumor have been advanced, therefore eight new indications of selective thyroid angiography for extraglandal change are proposed.


Subject(s)
Thyroid Gland/blood supply , Thyroid Neoplasms/diagnostic imaging , Adenocarcinoma/blood supply , Adenocarcinoma/diagnostic imaging , Adenocarcinoma, Papillary/blood supply , Adenocarcinoma, Papillary/diagnostic imaging , Adenoma/blood supply , Adenoma/diagnostic imaging , Adolescent , Adult , Aged , Angiography/methods , Humans , Middle Aged , Thyroid Neoplasms/blood supply
15.
Eur J Surg Oncol ; 14(1): 27-32, 1988 Feb.
Article in English | MEDLINE | ID: mdl-3345852

ABSTRACT

Severe and recurrent haemorrhage from ulcerating breast or skin lesions was controlled in seven of nine women with breast cancer. Arterial catheterisation and embolisation with a variety of materials (gelfoam, polyvinyl alcohol, steel coils, 50% dextrose) was used. Local anaesthesia only was needed, allowing very ill patients to be treated. This approach is the treatment of choice for severe haemorrhage in breast cancer.


Subject(s)
Adenocarcinoma, Papillary/blood supply , Breast Neoplasms/blood supply , Embolization, Therapeutic , Hemorrhage/therapy , Adenocarcinoma, Papillary/complications , Adenocarcinoma, Papillary/diagnostic imaging , Adult , Aged , Breast Neoplasms/complications , Breast Neoplasms/diagnostic imaging , Female , Hemorrhage/etiology , Humans , Middle Aged , Radiography
17.
Clin Radiol ; 30(1): 53-7, 1979 Jan.
Article in English | MEDLINE | ID: mdl-421424

ABSTRACT

Papillary adenocarcinoma of the kidney is an uncommon variant of renal tubular carcinoma, which on radiographic and ultrasonographic evaluation presents characteristically as a predominantly solid hypovascular or avascular mass. Surgery is required to distinguish this lesion from other solid renal lesions, which differs from the more common form of renal tubular carcinoma in several important respects.


Subject(s)
Adenocarcinoma, Papillary/diagnostic imaging , Kidney Neoplasms/diagnostic imaging , Adenocarcinoma, Papillary/blood supply , Aged , Angiography , Female , Humans , Kidney Neoplasms/blood supply , Male , Middle Aged , Ultrasonography
18.
J Surg Oncol ; 10(3): 205-9, 1978.
Article in English | MEDLINE | ID: mdl-651369

ABSTRACT

Angiography and nephrotomography are essential in evaluation of avascular or hypovascular space occupying lesions of the kidney. Ultrasound adds another dimension in differentiating solid from cystic masses. Two cases of tubular-papillary adenocarcinoma were reported. Their angiographic findings consisted of a few neovascularities. Nephrotomography and ultrasonography in the second case showed a solid mass.


Subject(s)
Adenocarcinoma, Papillary/diagnosis , Kidney Neoplasms/diagnosis , Adenocarcinoma, Papillary/blood supply , Angiography , Diagnosis, Differential , Humans , Kidney Diseases, Cystic/diagnostic imaging , Kidney Neoplasms/blood supply , Male , Middle Aged , Tomography, X-Ray , Ultrasonography
19.
J Urol ; 115(5): 514-9, 1976 May.
Article in English | MEDLINE | ID: mdl-1271541

ABSTRACT

Of 72 patients with renal cell carcinoma 19 were found to have an angiographic avascular neoplasm. These avascular tumors have a lower incidence of vein and capsule invasion than vascular tumors. Among these avascular cancers papillary adenocarcinoma was the predominant histologic pattern. Patients with papillary tumors seem to have a lower clinical stage and increased survival rate than patients with non-papillary tumors.


Subject(s)
Adenocarcinoma, Papillary/blood supply , Carcinoma/blood supply , Kidney Neoplasms/blood supply , Adenocarcinoma, Papillary/pathology , Adenocarcinoma, Papillary/surgery , Adult , Aged , Carcinoma/pathology , Carcinoma/surgery , Female , Follow-Up Studies , Humans , Kidney/blood supply , Kidney Neoplasms/pathology , Kidney Neoplasms/surgery , Male , Middle Aged , Neoplasm Metastasis , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL